Measured at Week 6 vs placebo in a study
population that included bio-naïve and anti-TNFα
experienced patients.
1,2
Individual results may vary.
Measured at Week 52 vs placebo in a study
population that included bio-naïve and anti-TNFα
experienced patients.
1,2
Individual results may vary.
For adults with moderately to severely active ulcerative
colitis (UC) when other therapies have not worked well
enough or cannot be tolerated.
See the data